000788 北大医药
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)8.6909.3973.1634.0843.272
总资产报酬率 ROA (%)6.1965.8361.7482.1481.780
投入资产回报率 ROIC (%)8.0648.5532.7083.1852.483

边际利润分析
销售毛利率 (%)27.02826.81932.45237.17041.093
营业利润率 (%)13.3238.3493.5763.4412.768
息税前利润/营业总收入 (%)13.3828.3353.4223.9613.491
净利润/营业总收入 (%)11.0456.6992.0222.6681.929

收益指标分析
经营活动净收益/利润总额(%)90.849117.925125.773114.609173.007
价值变动净收益/利润总额(%)5.309-0.137-1.560-2.1790.000
营业外收支净额/利润总额(%)1.5710.207-5.586-1.261-0.010

偿债能力分析
流动比率 (X)3.7942.5982.1211.8771.980
速动比率 (X)3.4832.3461.9301.7331.865
资产负债率 (%)23.08633.89741.70447.77947.483
带息债务/全部投入资本 (%)5.8445.5937.63913.86319.772
股东权益/带息债务 (%)1,589.6951,656.9411,169.008592.443374.878
股东权益/负债合计 (%)333.287195.096139.846109.751111.061
利息保障倍数 (X)-87.115-262.33194.8457.0364.824

营运能力分析
应收账款周转天数 (天)192.338196.124197.805206.175191.419
存货周转天数 (天)50.02944.54543.28641.06632.809